(III-1A.5.o) 49-year old female with cardiac failure and mitochondrial myopathy M. Dzieciuch-Rojek, P. Rubiś MD, PhD, S. Wiśniowska-Śmiałek MD, J. Stępniewski MD, D. Kudliński MD, A. Leśniak-Sobelga MD, PhD, M. Kostkiewicz MD, PhD, Prof. P. Podolec MD, PhD



EXPERT: Assoc. Prof. Bogusław Kapelak MD, PhD
Affiliation: Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland
There are indications for heart transplantation in this patient. A very important issue is the comprehensive assessment of the patient before surgery, in particular neurological evaluation for possible post-operative complications (if there is a risk of respiratory failure) and the ability of the patient to participate in post-transplant rehabilitation.
EXPERT: Prof. Andrzej Rudziński MD, PhD
Affiliation: Department of Cardiology, Pediatric Institute, Jagiellonian University Medical College, Krakow, Poland
Neurological consultation is indicated for the impact of the anticipated post-transplantation immunosuppression for comorbid neurological disease.

EXPERT: Paweł Rubiś MD, PhD
Affiliation: Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland
The patient was neurologically consulted and no contraindications to HTx were found.


1. The patient is eligible for heart transplantation surgery.
2. It is recommended to consult specialists neurologist, pulmonologist and medical rehabilitation for optimal preparation of the patient for HTx and plan the best post-operative care.
3. The patient should be presented to the Transplantation Team to begin the preparatory procedures for the operation.


“Development of the European Network in Orphan Cardiovascular Diseases”
„Rozszerzenie Europejskiej Sieci Współpracy ds. Sierocych Chorób Kardiologicznych”

This entry was posted in 1. Dilated cardiomyopathy, 5. Medication-induced, A. Genetic, Case presentations, III. Rare diseases of the heart (cardiomyopathies). Bookmark the permalink.

Comments are closed.